000			01939 a2200541 4500
005			20250511164940.0
264		0	_c19750702
008			197507s 0 0 eng d
022			_a0008-6363
024	7		_a10.1093/cvr/9.1.81 _2doi
040			_aNLM _beng _cNLM
100	1		_aRydén, L
245	0	0	_aElectrophysiological effects of the antiarrhythmic agent QX-572 in the human heart with special reference to rate-induced changes in effective refractory periods. _h[electronic resource]
260			_bCardiovascular research _cJan 1975
300			_a81-94 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAnti-Arrhythmia Agents _xpharmacology
650	0	4	_aArrhythmias, Cardiac _xdrug therapy
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aBundle of His _xdrug effects
650	0	4	_aCarbamates _xpharmacology
650	0	4	_aCardiac Catheterization
650	0	4	_aClinical Trials as Topic
650	0	4	_aElectrocardiography
650	0	4	_aElectrodes
650	0	4	_aElectrophysiology
650	0	4	_aFemale
650	0	4	_aHeart Atria _xdrug effects
650	0	4	_aHeart Conduction System _xdrug effects
650	0	4	_aHeart Diseases _xdrug therapy
650	0	4	_aHeart Rate _xdrug effects
650	0	4	_aHeart Ventricles _xdrug effects
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeural Conduction _xdrug effects
650	0	4	_aPacemaker, Artificial
650	0	4	_aParesthesia _xchemically induced
650	0	4	_aQuaternary Ammonium Compounds _xadverse effects
650	0	4	_aRefractory Period, Electrophysiological _xdrug effects
650	0	4	_aSinoatrial Node _xdrug effects
700	1		_aOlsson, B
700	1		_aKvasnicka, J
773	0		_tCardiovascular research _gvol. 9 _gno. 1 _gp. 81-94
856	4	0	_uhttps://doi.org/10.1093/cvr/9.1.81 _zAvailable from publisher's website
999			_c1098575 _d1098575